CRON
Cronos Group, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.52
+4.02%Forward multiples
Based on analyst estimates
- P/E forward
- 15.98x
- P/E 2026E
- 20.74x
- P/E 2027E
- 19.15x
- P/E 2028E
- 18.34x
- P/S forward
- 4.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.39x
- PEG TTM
- 0.90x
- Price / book
- 1.21x
- Price / sales
- 5.75x
- Price / cash flow
- 21.55x
Enterprise value
- Enterprise value
- $548.4M
- EV / sales
- 2.43x
- EV / EBITDA
- 48.27x
- EV / EBIT
- 43.40x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026